Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CNMD | Common Stock | Options Exercise | $0 | +335 | +11.43% | $0.00 | 3.27K | Jun 1, 2023 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CNMD | Rsus (restricted Stock Units) | Options Exercise | $0 | -335 | -100% | $0.00* | 0 | Jun 1, 2023 | Common Stock | 335 | $0.00 | Direct | F1 |
transaction | CNMD | Rsus (restricted Stock Units) | Award | $0 | +302 | $0.00 | 302 | Jun 1, 2023 | Common Stock | 302 | $0.00 | Direct | F1 | |
transaction | CNMD | Options To Purchase Common Stock | Award | $0 | +2.83K | $0.00 | 2.83K | Jun 1, 2023 | Common Stock | 2.83K | $123.79 | Direct | F2 |
Id | Content |
---|---|
F1 | Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. |
F2 | The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. |